PLoS One:黑熊血清可防止人类肌肉萎缩,也是其扛过冬眠的秘密武器!

2022-08-03 生物探索 生物探索

对冬眠熊血清的脂质组学分析表明,内源性大麻素系统在冬眠期间发生了特异性改变,从而有助于调节脂肪和骨骼肌中的能量代谢。

对动物而言,冬眠是通过减少体力活动和全身新陈代谢,从而在食物匮乏和寒冷的冬季环境中生存的关键生存策略。黑熊为冬眠动物,每年需冬眠5-7个月。尽管每年有持续半年时间不活动,但黑熊仍能维持较好的肌肉质量和力量。研究表明,冬眠期间,黑熊对骨骼肌萎缩的抵抗力和新陈代谢的维持可能是通过体液或全身因素来实现的。冬眠熊的血清或血浆中可能含有一些全身循环因子,这些因子会影响骨骼肌蛋白质代谢的调节,并有助于在冬眠期间维持骨骼肌质量。

骨骼肌是人体中高度可塑的组织。通过体育锻炼增加收缩活动会触发骨骼肌肥大,转变为慢肌类型,并通过线粒体生物发生增加氧化能力。相比之下,长时间不活动或营养不良会导致人体代谢功能障碍,例如骨骼肌萎缩、转变为快肌类型以及能量代谢不足。由于骨骼肌质量的损失和代谢功能障碍与较短的健康寿命直接相关,因此良好的骨骼肌质量和代谢特征是人类健康生活的一大保证。黑熊血清中含有的物质恰好可以防止人类肌肉萎缩。

2022年1月,日本北海道大学研究团队在PLOS ONE发表题为“Supplementing cultured human myotubes with hibernating bear serum results in increased protein content by modulating Akt/FOXO3a signaling”的研究成果(图1)[1]。结果表明冬眠熊血清培养的人骨骼肌细胞的总蛋白质含量显着增加,可通过抑制由Akt-FOXO3a信号传导介导的蛋白质降解系统抑制蛋白质降解。

图1 研究成果(图源:[1])

本研究通过在体外培养的人骨骼肌细胞中添加冬眠熊血清(Hibernating bear serum,HBS),确定HBS是否会改变骨骼肌的蛋白质和能量代谢;分析了与非冬眠期血清(active period bear serum,ABS)相比,HBS是否会改变调节人类骨骼肌细胞中蛋白质和能量代谢的信号通路。

结果发现:

1、与ABS相比,HBS提高了人肌管中总蛋白质含量

经黑熊血清培养24小时后,人肌管并没有任何明显的形态变化或分化细胞核数量的增加。与ABS相比,HBS培养显着增加了人肌管总蛋白含量。

2、HBS诱导Akt/mTORC1通路的激活

本研究中使用了完全分化的肌管,因此细胞蛋白质含量的变化基本上反映了蛋白质合成和降解的平衡。鉴于HBS增加了总蛋白质含量,接下来检查了Akt的激活状态和mTORC1(mechanistic target of rapamycin complex 1)途径的机械靶点,这些途径可调节骨骼肌中蛋白质的合成。

与ABS相比,HBS培养的肌管中Akt在Thr308处的磷酸化(Akt激酶活性的指标)显着增加;此外,mTORC1活性的直接下游靶点S6K1磷酸化也在Thr389和Thr421/Ser424处显着增强;S6K1的总蛋白表达也增加;Ser473的Akt磷酸化和pan-Akt的表达水平没有改变;蛋白质合成的速率没有明显的变化。这些结果表明HBS处理会诱导Akt/mTORC1通路的激活,但并不直接诱导人骨骼肌细胞中蛋白质合成的激活。

3、HBS抑制人类骨骼肌细胞中蛋白质的降解

因为总蛋白质含量增加而蛋白质合成系统不受影响,研究人员探索了HBS对培养肌管中蛋白水解系统的影响。骨骼肌中存在两种主要的蛋白水解途径:自噬-溶酶体系统和泛素-蛋白酶体系统。微管相关蛋白1 LC3-II(light chain 3)是自噬体形成的标志物,在肌管中没有改变,表明培养的肌管中的自噬通量没有变化。相比之下,MuRF1(muscle RING-finger protein-1)(一种骨骼肌特异性E3泛素连接酶和已知的肌肉萎缩标志物)的表达在HBS处理后显着降低。Atrogin1蛋白表达没有改变。这些结果表明,HBS抑制人类骨骼肌细胞中通过泛素-蛋白酶体依赖性系统的蛋白质降解。

4、HBS增强Akt-FOXO轴

Akt-FOXO轴可能是骨骼肌细胞中泛素-蛋白酶体系统的潜在调节机制,特别是通过调节atrogin1和murf1基因的转录激活。FOXO3a在Ser253和Ser318/321位点的磷酸化,被Akt直接和间接磷酸化,对于核输出到胞质溶胶和抑制FOXO3a转录因子活性很重要。与ABS相比,HBS处理后肌管中FOXO3a的磷酸化和总表达显着增加。此外,HBS处理后细胞溶质FOXO3a显着增加,而核FOXO3a没有变化。这些结果表明,HBS促进了FOXO3a蛋白在胞质部分的磷酸化和螯合增加,这可能导致FOXO3a的转录活性降低。

5、HBS提高了IGF-1浓度

IGF-1是一种血清生长因子,可诱导骨骼肌中Akt-FOXO3a轴的激活。与ABS相比,HBS处理的骨骼肌细胞IGF-1含量显着更高。该结果表明,冬眠期间血清IGF-1量的增加会影响骨骼肌细胞中的Akt-FOXO3a途径,导致MuRF1表达降低,这是FOXO3a转录活性的潜在靶标。

6、HBS没有诱导培养的人骨骼肌细胞中的线粒体生物发生

先前的研究表明,骨骼肌中的线粒体生物发生在冬眠期间增强,因此,研究人员检测了HBS处理后培养的肌管中OXPHOS亚基蛋白的表达。研究发现大多数因素没有统计学上的显着变化,HBS处理后复合物III的表达有所下降。此外,线粒体生物发生调节因子(过氧化物酶体增殖物激活受体γ共激活因子1-α:Pgc1a)的基因表达水平和其他线粒体相关因子(线粒体解偶联蛋白3、细胞色素c、细胞色素c氧化酶亚基4和肉碱棕榈酰转移酶-1b)没有显着改变,但Pgc1b表达上调。因此,HBS处理不太可能诱导培养的人骨骼肌细胞中线粒体生物发生。

在本研究中,将HBS直接添加到培养的人骨骼肌细胞中,以分析全身体液因子对蛋白质代谢调节的影响。实验结果表明,HBS正向调节肌肉蛋白质代谢,可能是通过抑制由Akt-FOXO3a信号传导介导的蛋白质降解系统,从而导致总蛋白质含量的积累。研究中一个未解决的问题是除了IGF-1之外,HBS中的哪些成分会影响骨骼肌蛋白代谢。尽管在本研究中观察到IGF-1浓度增加,但在熊血清中总蛋白质含量正常化后发现这种情况无效。先前的研究报道,熊血清中的IGF-1浓度呈现出季节性变化,在活跃的夏季期间最高,在冬眠早期最低,然后在冬眠结束时再次升高。因此,如目前的结果所示,很难确定血清IGF-1是否起到维持培养的骨骼肌细胞中蛋白质含量的作用。

近年来,利用组学方法对冬眠熊的血清或组织中可能有助于代谢特征的新因子进行了广泛的探索。对冬眠熊血清的脂质组学分析表明,内源性大麻素系统在冬眠期间发生了特异性改变,从而有助于调节脂肪和骨骼肌中的能量代谢。在一项涉及miRNA测序和转录组分析的联合研究中,冬眠期间特异性诱导的三种循环microRNA的表达有助于在冬眠期间长期不活动的情况下预防静脉血栓栓塞。对于人类而言,探索黑熊冬眠期间直接有助于抑制骨骼肌蛋白水解的循环因子有助于研发药物来预防与治疗治疗与长期不活动相关的骨骼肌萎缩。

原始出处:

Miyazaki M, Shimozuru M, Tsubota T. Supplementing cultured human myotubes with hibernating bear serum results in increased protein content by modulating Akt/FOXO3a signaling. PLoS One. 2022 Jan 25;17(1):e0263085. doi: 10.1371/journal.pone.0263085.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739909, encodeId=0c8a1e3990911, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Sat Sep 17 19:56:00 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790424, encodeId=63661e9042449, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Sep 04 15:56:00 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696063, encodeId=abda16960638a, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sun Sep 18 00:56:00 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584188, encodeId=ff0f158418845, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Thu Aug 04 13:56:00 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236545, encodeId=74b412365456a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Thu Aug 04 11:18:56 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739909, encodeId=0c8a1e3990911, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Sat Sep 17 19:56:00 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790424, encodeId=63661e9042449, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Sep 04 15:56:00 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696063, encodeId=abda16960638a, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sun Sep 18 00:56:00 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584188, encodeId=ff0f158418845, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Thu Aug 04 13:56:00 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236545, encodeId=74b412365456a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Thu Aug 04 11:18:56 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739909, encodeId=0c8a1e3990911, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Sat Sep 17 19:56:00 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790424, encodeId=63661e9042449, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Sep 04 15:56:00 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696063, encodeId=abda16960638a, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sun Sep 18 00:56:00 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584188, encodeId=ff0f158418845, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Thu Aug 04 13:56:00 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236545, encodeId=74b412365456a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Thu Aug 04 11:18:56 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-09-18 chendoc252
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739909, encodeId=0c8a1e3990911, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Sat Sep 17 19:56:00 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790424, encodeId=63661e9042449, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Sep 04 15:56:00 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696063, encodeId=abda16960638a, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sun Sep 18 00:56:00 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584188, encodeId=ff0f158418845, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Thu Aug 04 13:56:00 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236545, encodeId=74b412365456a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Thu Aug 04 11:18:56 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1739909, encodeId=0c8a1e3990911, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Sat Sep 17 19:56:00 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790424, encodeId=63661e9042449, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Sep 04 15:56:00 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696063, encodeId=abda16960638a, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Sun Sep 18 00:56:00 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584188, encodeId=ff0f158418845, content=<a href='/topic/show?id=f3308101eee' target=_blank style='color:#2F92EE;'>#肌肉萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81017, encryptionId=f3308101eee, topicName=肌肉萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=177b17012429, createdName=12498ebem24暂无昵称, createdTime=Thu Aug 04 13:56:00 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236545, encodeId=74b412365456a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Thu Aug 04 11:18:56 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-08-04 ms5000000338064393

    学习了

    0

相关资讯

.Science:治疗肌肉萎缩不妨“以牙还牙”

与狗“共事”的研究人员修补了一个引发杜兴氏肌肉营养不良症(DMD)的基因故障,利用的手段则是进一步破坏该DNA。这种利用了基因组编辑器CRISPR的不寻常方法,使突变基因得以重新产生关键肌肉蛋白。这个首次在大型动物身上实现的壮举点燃了这样一种希望,即此类基因手术或许有一天能预防或者治疗这种致残甚至致命的疾病。据估测,目前全球有30万名男孩受DMD影响。这项日前在线发表于《科学》杂志的研究,由美

JCSM:补充甘氨酸和支链氨基酸对慢性血液透析患者肠道屏障和微生物群的影响

补充BCAA和甘氨酸对慢性血液透析患者的细胞因子、食欲介质、肠道通透性、内源性大麻素或粪便 IgA 的血清水平均没有影响

Aging Cell:Sulforaphane通过Nrf2信号改善年龄相关的心脏和肌肉功能障碍

尽管Nrf2(一种调节细胞保护基因表达的转录因子)在肌肉相关疾病中的作用仍然不甚明确,但它已显示出对肌肉萎缩和心血管疾病的有益特性。

18岁少年都肌萎缩了,医生却赶他回去不用治?

您这个病啊,幸亏来得早,再晚几年,它可就自己好了。

Cell Death Dis:CACNA1H表达下调诱导骨骼肌萎缩导致骨盆底功能障碍

骨骼肌是人体最重要的器官之一,约占总体重的50%。骨盆底肌肉(PFM)是骨盆底的重要组成部分,其功能障碍会引起骨盆底功能障碍(PFD)相关疾病,包括骨盆器官脱垂、大小便失禁。这些疾病影响着世界各地的妇

Neurology: SEPT9突变所致的慢性进行性肥厚性臂丛病1例

51岁男性,自21岁起开始出现缓慢进行性肌肉萎缩,无力和右上肢感觉异常。患者已故的母亲有一次右上肢痛性轻瘫发作。查体可见严重的肌萎缩和右上肢感觉减退。神经影像学可见明显的右侧臂丛病(图1-2)。神经电